Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collier

Showing results (361-370 of 379) with videos related to

Pageof 38
Sort By:
Protein Expression and Purification|June 19, 2007
A Bacillus subtilis fusion protein system to produce soybean Bowman-Birk protease inhibitorGudrun Vogtentanz, Katherine D Collier, Michael Bodo, et al.
International Journal of Sport Nutrition and Exercise Metabolism|May 19, 2024
Myths and Methodologies: Standardisation in Human Physiology Research-Should We Control the Controllables?Lucy H Merrell, Oliver J Perkin, Louise Bradshaw, et al.
Experimental Physiology|May 19, 2024
Myths and Methodologies: Standardisation in human physiology research-should we control the controllables?Lucy H Merrell, Oliver J Perkin, Louise Bradshaw, et al.
American Journal of Medical Genetics|February 16, 1996
A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22)M Gill, H Vallada, D Collier, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
Annals of the Rheumatic Diseases|March 17, 2006
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine studyD Khanna, D E Furst, R D Hays, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|September 16, 2015
Zebrafish neurobehavioral phenomics for aquatic neuropharmacology and toxicology researchAllan V Kalueff, David J Echevarria, Sumit Homechaudhuri, et al.
Expert Opinion on Drug Discovery|November 13, 2015
Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studiesJudith R Homberg, Evan J Kyzar, Adam Michael Stewart, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma SpheroidsEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Psychiatry Research|May 30, 1997
A linkage study of schizophrenia to markers within Xp11 near the MAOB geneJ Dann, L E DeLisi, M Devoto, et al.
Pageof 38

Showing results (361-370 of 379) with videos related to

Sort By:
Pageof 38
Protein Expression and Purification|June 19, 2007
A Bacillus subtilis fusion protein system to produce soybean Bowman-Birk protease inhibitorGudrun Vogtentanz, Katherine D Collier, Michael Bodo, et al.
International Journal of Sport Nutrition and Exercise Metabolism|May 19, 2024
Myths and Methodologies: Standardisation in Human Physiology Research-Should We Control the Controllables?Lucy H Merrell, Oliver J Perkin, Louise Bradshaw, et al.
Experimental Physiology|May 19, 2024
Myths and Methodologies: Standardisation in human physiology research-should we control the controllables?Lucy H Merrell, Oliver J Perkin, Louise Bradshaw, et al.
American Journal of Medical Genetics|February 16, 1996
A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22)M Gill, H Vallada, D Collier, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
Annals of the Rheumatic Diseases|March 17, 2006
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine studyD Khanna, D E Furst, R D Hays, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|September 16, 2015
Zebrafish neurobehavioral phenomics for aquatic neuropharmacology and toxicology researchAllan V Kalueff, David J Echevarria, Sumit Homechaudhuri, et al.
Expert Opinion on Drug Discovery|November 13, 2015
Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studiesJudith R Homberg, Evan J Kyzar, Adam Michael Stewart, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma SpheroidsEmily E Seiden, Spencer M Richardson, Leah A Everitt, et al.
Psychiatry Research|May 30, 1997
A linkage study of schizophrenia to markers within Xp11 near the MAOB geneJ Dann, L E DeLisi, M Devoto, et al.
Pageof 38